The 2025 State of Pharma Launch Excellence Industry Report has just been released, and you can download it now.

The pharmaceutical landscape is evolving rapidly, with more launches failing than ever before. This brand new report - the most detailed and accurate to date - provides a full update on the current state of pharmaceutical launches, examining why these failures are occurring, which specific launches are struggling, and what strategies companies are implementing to overcome these challenges. This comprehensive analysis names key drugs, organisations, and insights to help you navigate regulatory hurdles and position your launches for success in this evolving landscape.

Download your complimentary copy of the brand new 45 page report now for an in-depth look at:

• How generative AI is transforming pharma launch strategies
• Key therapeutic areas like oncology, immunology, and obesity treatments leading future launches
• Navigating new regulatory challenges, including U.S. price controls and European reforms
• The critical role of cross-functional coordination in achieving launch success
• Why specialty drugs continue to dominate market growth
• The rise of independent launches by smaller biotech firms
• Addressing healthcare system capacity issues amid rising specialty drug costs
  

#PHLEX united the global launch community to navigate post-pandemic challenges in a competitive digital and regulatory environment, optimising strategy for successful product commercialisation. See who attended last December the Pharma Launch Excellence Summit in London! 

Get your complimentary copy below 

[Speaker Interview] Sherif Elhaw, Director, Emerging Markets, Launch Excellence Lead at Pfizer shares insights on the evolving pharmaceutical launch landscape, emphasizing the importance of innovation, data-driven decision-making, and overcoming cognitive biases for successful product launches.

[Speaker Interview] Paula Albuquerque, Assets Strategic Planning, at UCB shares insights on evolving landscape of launch excellence, highlighting the importance of strategic agility, market access collaboration, and sustainable practices to ensure both corporate success and equitable patient outcomes.

[Speaker Video Interview] Simone Rebora, Global Marketing Director at Ipsen shares insights on building expertise, evolving in the industry, mastering successful launches and adapting global launch strategies.